256 related articles for article (PubMed ID: 24437140)
1. [New anticoagulants in patients with atrial fibrillation].
Diener HC; Weber R
MMW Fortschr Med; 2013 May; 155(8):55-6, 58. PubMed ID: 24437140
[No Abstract] [Full Text] [Related]
2. An indirect comparison of dabigatran, rivaroxaban and apixaban for atrial fibrillation.
Mantha S; Ansell J
Thromb Haemost; 2012 Sep; 108(3):476-84. PubMed ID: 22740145
[TBL] [Abstract][Full Text] [Related]
3. [Gastrointestinal bleeding under treatment with new oral anticoagulants].
Konturek P; Hess T
MMW Fortschr Med; 2014 Feb; 156(2):50-2. PubMed ID: 24934056
[No Abstract] [Full Text] [Related]
4. Comparative efficacy and safety of new oral anticoagulants in patients with atrial fibrillation.
Schneeweiss S; Gagne JJ; Patrick AR; Choudhry NK; Avorn J
Circ Cardiovasc Qual Outcomes; 2012 Jul; 5(4):480-6. PubMed ID: 22787066
[TBL] [Abstract][Full Text] [Related]
5. [Differential therapy with the new anticoagulants, 5].
Stiefelhagen P
MMW Fortschr Med; 2013 May; 155(9):20. PubMed ID: 23951642
[No Abstract] [Full Text] [Related]
6. Comparison of efficacy and safety of dabigatran, rivaroxaban and apixaban in patients with atrial fibrillation using network meta-analysis.
Harenberg J; Marx S; Diener HC; Lip GY; Marder VJ; Wehling M; Weiss C
Int Angiol; 2012 Aug; 31(4):330-9. PubMed ID: 22801398
[TBL] [Abstract][Full Text] [Related]
7. [Stroke risk--atrial fibrillation].
Dabitz R; Ochs G
MMW Fortschr Med; 2012 Nov; 154(19):53-6. PubMed ID: 23173288
[No Abstract] [Full Text] [Related]
8. [Prophylaxis of stroke and embolisms in atrial fibrillation--what is new in the guidelines?].
Lewalter T
MMW Fortschr Med; 2012 Mar; 154(5):50-2, 54. PubMed ID: 22624265
[No Abstract] [Full Text] [Related]
9. Meta-analysis of efficacy and safety of new oral anticoagulants (dabigatran, rivaroxaban, apixaban) versus warfarin in patients with atrial fibrillation.
Miller CS; Grandi SM; Shimony A; Filion KB; Eisenberg MJ
Am J Cardiol; 2012 Aug; 110(3):453-60. PubMed ID: 22537354
[TBL] [Abstract][Full Text] [Related]
10. Oral anticoagulation in atrial fibrillation: balancing the risk of stroke with the risk of bleed.
Kosar L; Jin M; Kamrul R; Schuster B
Can Fam Physician; 2012 Aug; 58(8):850-8. PubMed ID: 22893338
[No Abstract] [Full Text] [Related]
11. [Anticoagulant therapy in stroke patients].
Kraglund KL; Husted SE; Modrau B; Grove EL
Ugeskr Laeger; 2013 Jan; 175(5):265-8. PubMed ID: 23369327
[TBL] [Abstract][Full Text] [Related]
12. Cardiology patient page. Patient guide for taking the non-vitamin K antagonist oral anticoagulants for atrial fibrillation.
Lane DA; Wood K
Circulation; 2015 Apr; 131(16):e412-5. PubMed ID: 25901074
[No Abstract] [Full Text] [Related]
13. [Prophylaxis of thromboembolism in atrial fibrillation: new oral anticoagulants and left atrial appendage closure].
Zeus T; Kelm M; Bode C
Dtsch Med Wochenschr; 2015 Aug; 140(16):1213-5. PubMed ID: 26261929
[TBL] [Abstract][Full Text] [Related]
14. Dabigatran, ROCKET atrial fibrillation, and beyond: basic science, mechanisms of agents, monitoring, and reversal.
Bauer KA
Stroke; 2013 Jun; 44(6 Suppl 1):S38-40. PubMed ID: 23709725
[No Abstract] [Full Text] [Related]
15. Novel oral anticoagulants for stroke prevention in patients with atrial fibrillation.
Berman JP; Halperin JL
Hosp Pract (1995); 2013 Feb; 41(1):37-48. PubMed ID: 23466966
[TBL] [Abstract][Full Text] [Related]
16. Concerns about studies investigating new anticoagulant drugs for stroke prevention in atrial fibrillation.
Stöllberger C; Finsterer J
J Neurol; 2012 Jan; 259(1):168-9. PubMed ID: 22124666
[No Abstract] [Full Text] [Related]
17. Non-vitamin K antagonist oral anticoagulants in cardiovascular disease management: evidence and unanswered questions.
Cheng JW; Barillari G
J Clin Pharm Ther; 2014 Apr; 39(2):118-35. PubMed ID: 24383983
[TBL] [Abstract][Full Text] [Related]
18. [Atrial fibrillation: what the GP needs to know].
Diener HC; Kaeufer T; Bode C
MMW Fortschr Med; 2011 Sep; 153(38):44-7; quiz 48. PubMed ID: 21977796
[No Abstract] [Full Text] [Related]
19. Indirect comparisons of new oral anticoagulant drugs for efficacy and safety when used for stroke prevention in atrial fibrillation.
Lip GY; Larsen TB; Skjøth F; Rasmussen LH
J Am Coll Cardiol; 2012 Aug; 60(8):738-46. PubMed ID: 22575324
[TBL] [Abstract][Full Text] [Related]
20. {blacktriangledown} Apixaban and {blacktriangledown} rivaroxaban for stroke prevention in AF.
Drug Ther Bull; 2014 Jan; 52(1):6-9. PubMed ID: 24401533
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
